CLOV (Clover Health Investments) Total Receivables: $203 Mil (As of Mar. 2026)


CLOV Clover Health Investments Corp CLOV
81 GF Score
Price $5.41
GF Value $3.96
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Clover Health Investments Total Receivables?

Clover Health Investments CLOV +3.64% 81 Total Receivables is $203 Mil as of Mar. 2026. GuruFocus rates CLOV with a GF Score™ of 81/100 and a GF Value™ of $3.96 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Clover Health Investments's Total Receivables for the quarter that ended in Mar. 2026 was $203 Mil.

Clover Health Investments Total Receivables Related Terms

Clover Health Investments Total Receivables Historical Data

* Premium members only.

The historical data trend for Clover Health Investments's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments Total Receivables Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial 109.42 167.55 86.24 92.79 158.74

Clover Health Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 138.26 131.35 103.51 158.74 202.69
CLOV
81GF Score
Clover Health Investments Corp CLOV
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover Health Investments Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $203 Mil mean?
Clover Health Investments (CLOV) has a Total Receivables of $203 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Clover Health Investments and its competitors.
Is Clover Health Investments' Total Receivables too high?
Clover Health Investments' current Total Receivables is $203 Mil. Overall, Clover Health Investments has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' Total Receivables compare to PGNY and ALHC?
Clover Health Investments' Total Receivables of $203 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Healthcare Plans company?
A good Total Receivables depends on the Healthcare Plans industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Clover Health Investments and its competitors. Clover Health Investments's current Total Receivables is $203 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.96, compared to a current price of $5.41 — trading 36.6% above its estimated fair value. The current Total Receivables is $203 Mil. Clover Health Investments' overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current Total Receivables is $203 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (CLOV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of $5.41 is trading 36.6% above its estimated GF Value™ of $3.96. GuruFocus considers Clover Health Investments to be Significantly Overvalued.

Key valuation signals for CLOV:

  • Total Receivables: $203 Mil
  • GF Value™: $3.96 vs. price of $5.41 (36.6% above fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clover Health Investments Business Description

Other Exchanges 7QD:GermanyCLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
81GF Score

Get the complete analysis for CLOV

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.41
Price
$3.96
GF Value